What are Mission Vision & Core Values of Myriad Company?

Myriad Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What are the Mission, Vision, and Core Values of Myriad Genetics, Inc.?

Mission and vision statements are foundational for any thriving enterprise, articulating its purpose and charting its future. For Myriad Genetics, Inc., these statements are crucial in the complex landscape of genetic testing and precision medicine, guiding their strategic decisions.

The global molecular diagnostics market was valued at approximately $25.75 billion in 2024, projected to reach $33.08 billion by 2030. Myriad's mission, vision, and core values act as a strategic compass, guiding critical business decisions and shaping their corporate identity. For a deeper dive into the external factors influencing the company, consider reviewing the Myriad PESTEL Analysis.

The Myriad Company mission focuses on empowering individuals through genetic insights. This commitment is evident in their diagnostic solutions, which provide crucial information for personalized healthcare decisions. The company's dedication to improving global health outcomes is central to its purpose.

Customer-Centric Focus

Myriad Company's mission targets 'all' individuals, emphasizing a broad commitment to global health and well-being.

Core Product/Service

The company specializes in 'revealing the answers inside each of us' through genetic and molecular diagnostic tests.

Unique Value Proposition

Myriad empowers individuals with insights, facilitating informed health decisions rather than just providing test results.

Hereditary Cancer Testing

Tests like MyRisk Hereditary Cancer help individuals understand genetic predispositions for proactive prevention or early diagnosis.

Mental Health Optimization

The GeneSight Psychotropic test guides treatment by showing how genes influence responses to mental health medications.

Investment in Innovation

R&D expenses reached $167.5 million in Fiscal Year 2023, demonstrating a commitment to continuous innovation.

Myriad Company's mission statement clearly defines its target customers as 'all' individuals, emphasizing a broad commitment to global health and well-being. The core product/service offered is 'revealing the answers inside each of us,' which refers to their genetic and molecular diagnostic tests designed to assess disease risk, guide treatment, and predict responses to medications. The unique value proposition lies in 'empowering every individual' through these insights, positioning Myriad as a facilitator of informed health decisions rather than just a testing provider. This mission is profoundly customer-centric, focusing on improving patient lives through personalized medicine. For instance, the company's hereditary cancer testing, such as MyRisk Hereditary Cancer, helps individuals understand their genetic predisposition, enabling proactive prevention or earlier diagnosis. Similarly, the GeneSight Psychotropic test reflects this mission by guiding healthcare providers on how a patient's genes may influence their response to mental health medications, thereby optimizing treatment outcomes. Myriad's consistent investment in research and development, with R&D expenses reaching $167.5 million in Fiscal Year 2023, further demonstrates its commitment to this mission through continuous innovation. For more insights into the company's strategic direction, explore the Growth Strategy of Myriad. Understanding Myriad Company's core values is essential to grasping its operational philosophy.

Myriad SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Myriad Company's vision is to be a global leader in genetic testing and precision medicine, providing insights that empower individuals to manage their health and enable healthcare providers to enhance disease detection, treatment, and prevention. This forward-looking vision emphasizes innovation and global impact.

Vision for Health Control

Myriad Company's vision aims to help individuals take control of their health through genetic insights.

Empowering Providers

The vision supports healthcare providers in better detecting, treating, and preventing diseases.

Leadership in Precision Medicine

Myriad Company strives to maintain its position as a leader in precision medicine.

Global Impact

The company's vision extends to making a worldwide impact on health outcomes.

Innovation Focus

Myriad Company's vision is driven by continuous innovation in genetic testing.

Future-Oriented Growth

The vision guides strategic growth and development for future healthcare advancements.

Myriad Company's vision is to be a leader in genetic testing and precision medicine, providing insights that help people take control of their health and enable healthcare providers to better detect, treat, and prevent disease. This vision is supported by the company's strong financial performance, with full-year 2024 revenue reaching $838 million, marking an 11% year-over-year growth. The strategic focus on expanding its oncology portfolio, including the anticipated commercial launch of the Precise Liquid and Precise MRD assays in 2025, underscores Myriad Company's vision for the future and its commitment to innovation. Understanding Myriad Company's core values and strategic vision is crucial for stakeholders. For more insights into the market, explore the Competitors Landscape of Myriad. Myriad Company's guiding principles and values are integral to its mission statement analysis, ensuring its strategic vision and values align with its goals.

Myriad PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Myriad Company's core values are fundamental to its operational framework and strategic direction. These principles guide employee behavior, foster a collaborative environment, and drive innovation in genetic testing, ensuring the company remains a leader in precision medicine. The four core values are Collaborative, Innovative, Inclusive, and Caring.

Collaborative

This value emphasizes teamwork and partnership, both internally and externally, to achieve shared goals. It manifests in product development through strategic collaborations, such as the acquisition of assets from Intermountain Precision Genomics in January 2024 to scale tumor profiling and liquid biopsy tests, and partnerships like the one with jscreen in Q4 2024 to expand access to genetic testing.

Innovative

This value drives Myriad Company's continuous pursuit of new technologies and solutions in genetic testing. It is evident in product development with the expected commercial launch of the Precise Liquid and Precise MRD assays in 2025, aimed at improving patient outcomes and achieving double-digit growth.

Inclusive

This value reflects Myriad Company's dedication to diversity, equity, and accessibility in its operations and offerings. It manifests in product development by striving to create accessible, inclusive tests that cover all ancestries, leveraging the largest repository of comparative data. In corporate culture, Myriad prioritizes diversity and inclusion, with 84% of employees in 2024 stating it's a great place to work, 27 percentage points higher than the typical U.S. company.

Caring

This value underscores Myriad Company's patient-centric approach and its commitment to improving lives. It is evident in customer relations by providing genetic counseling services to help individuals interpret test results and make informed health decisions. In business practices, it translates to focusing on clinical outcomes and patient care, as highlighted by their Quality, Innovation, and Corporate Responsibility Report.

These core values of Myriad Company collectively differentiate it in the competitive molecular diagnostics market. To understand how these principles shape its strategic direction, explore the next chapter on how Myriad Company's mission and vision influence its strategic decisions. For a deeper dive into the company's foundational principles, read our article on Mission, Vision & Core Values of Myriad.

Myriad Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

A company's mission and vision are foundational elements that steer its strategic direction and decision-making processes. These statements articulate the organization's fundamental purpose and its aspirations for the future, influencing everything from product development to market expansion.

Myriad Company's Mission and Vision: A Strategic Compass

Myriad Genetics' mission and vision statements are deeply integrated with its business strategy, directly guiding its strategic decisions and operational focus.

• The company's mission to 'advance health and well-being for all' underpins its strategic focus on the Cancer Care Continuum (CCC) as a primary growth engine.
• This focus is exemplified by increased R&D investment in assays like Precise MRD, with an anticipated early access launch in the first half of 2026.
• The vision to 'provide insights that help people take control of their health' drives market expansion and partnership strategies, such as the February 2025 collaboration with PATHOMIQ to integrate an AI technology platform.
• These guiding principles influence long-term planning, including continued investment in new product development and revenue growth initiatives.

Strategic Alignment with Mission

Myriad's strategic decision to concentrate on the Cancer Care Continuum (CCC) as its core growth engine, as highlighted in its 2024-2025 strategy, directly reflects its mission to advance health and well-being for all by addressing critical patient care needs with genetic insights.

Vision-Driven Market Expansion

The company's vision to empower individuals to control their health fuels its market expansion and partnership strategies, such as the February 2025 agreement with PATHOMIQ to enhance its oncology portfolio with AI technology.

Financial Performance and Strategic Execution

Full-year 2024 revenue reached $838 million, an 11% year-over-year increase, with Q2 2025 revenue at $213 million, a 5% year-over-year rise (excluding certain factors), demonstrating progress in executing its strategy. CEO Sam Raha, appointed President and CEO on April 30, 2025, is focused on unlocking the company's potential through strategic implementation and capability enhancement.

Operational Excellence

Operational excellence is a key focus, with 88% of samples processed within industry-leading turnaround times as of July 2024, aligning with the company's commitment to efficient and effective patient care.

Addressing Market Challenges

Despite challenges, such as a 20% decline in Pharmacogenomics revenue in Q1 2025 due to reduced coverage for GeneSight by UnitedHealthcare, the company's strategic vision guides its efforts to navigate market dynamics and drive future growth.

Long-Term Planning and Investment

Long-term planning is shaped by the mission and vision, directing continued investment in new product development and programs aimed at revenue growth, ensuring the company remains at the forefront of genetic testing and insights.

Myriad's mission and vision are integral to its strategic decisions, guiding its focus on areas like the Cancer Care Continuum and influencing partnerships. Explore how these principles can be further refined in the next chapter on Core Improvements to Company's Mission and Vision.

Myriad Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Enhancing Myriad Company's mission and vision statements can better align with current industry trends and future opportunities. These improvements focus on broadening their scope and reinforcing their commitment to ethical practices.

Emphasize Proactive Health Management

By explicitly incorporating a focus on proactive health management and preventive care, the company can better capture the growing wellness market, valued at $7 trillion in 2024. This refinement would align with empowering individuals for lifelong proactive health through genetic insights.

Integrate Ethical Considerations and Societal Impact

Addressing ethical considerations and societal impact more explicitly positions the company as an ethical steward in precision medicine. This includes a commitment to responsibly advancing genetic science for global health equity and ethical innovation.

Adapt to Evolving Technologies and Consumer Behaviors

Adapting statements to address emerging technologies like AI and changing consumer behaviors regarding data privacy is crucial. This ensures the company remains relevant and trustworthy in the precision medicine space.

Capitalize on Industry Growth and Sustainability

These suggestions are framed as growth opportunities, allowing the company to adapt its core principles to capitalize on evolving industry trends. The molecular diagnostics sector, for instance, is projected for significant growth, making strategic alignment important for sustainability.

Understanding the Myriad Company's mission, vision, and core values is fundamental to grasping its strategic direction and operational philosophy. The mission statement typically outlines the company's fundamental purpose, defining what it does, for whom, and how it aims to achieve its objectives. For instance, the mission might focus on advancing health through genetic insights. The vision statement, on the other hand, paints a picture of the company's desired future state, articulating its long-term aspirations and the impact it hopes to make. A potential vision could be to lead the field in personalized medicine, transforming patient care globally. The core values serve as the guiding principles that shape the company's culture, decision-making, and employee behavior. These values might include integrity, innovation, and patient-centricity, reflecting the company's commitment to ethical conduct and scientific advancement. Analyzing the Brief History of Myriad can provide context for how these guiding principles have evolved and been applied over time. The company's purpose is intrinsically linked to its mission, driving its strategic goals and the development of its products and services. In 2024, the company's focus on expanding its portfolio in areas like oncology and women's health demonstrates its commitment to achieving these goals. The company's culture is a direct manifestation of its core values, influencing employee interactions and the overall work environment. Understanding Myriad Company's core values in action can be seen in its dedication to rigorous scientific validation and transparent communication with healthcare providers and patients alike. The importance of Myriad Company's mission lies in its ability to provide a clear direction and a sense of purpose for all stakeholders. The mission and vision of Myriad Company are not static; they are dynamic elements that adapt to scientific breakthroughs and market demands, ensuring the company remains at the forefront of genetic diagnostics.